Skip to main content
Signal8
Bratton Capital Management, L.P. logo

Bratton Capital Management, L.P.

CIK: 1723787

Last 13F

Nov 3, 2026

Next 13F

Filed · awaiting next quarter

13F Portfolio Value

$45.42M

Not total AUM

New Positions

0

Increased

0

Decreased

0

Exit Positions

0

Holdings (1)

Q3 2026 13F, quarter ended Sep 30, 2026, filed Nov 3, 2026

  • AQUESTIVE THERAPEUTICS INC logo
    AQST

    AQUESTIVE THERAPEUTICS INC

    $45.42M

    9.81M sh100.00%+0.0%

1-1 of 1

Sector Allocation

SEC Filings

FormDescriptionFiled

About Bratton Capital Management, L.P.

Bratton Capital Management, L.P. is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 1723787). Signal8 holds 21 13F filings from it. Its SEC filings list Texas as its state of incorporation.

Its most recent 13F holdings report covers Q3 2026 (the quarter ended Sep 30, 2026) and was filed on Nov 3, 2026. That report lists 1 security, not counting options, the same number as in Q2 2026.

Its largest reported position is AQUESTIVE THERAPEUTICS INC (AQST).

Recent 13F filings by Bratton Capital Management, L.P.

  • Q3 2026: 13F-HR filed Nov 3, 2026, listing 1 security.
  • Q2 2026: 13F-HR filed Aug 11, 2026, listing 1 security.
  • Q1 2026: 13F-HR filed May 13, 2026, listing 1 security.
  • Q4 2025: 13F-HR filed Feb 17, 2026, listing 1 security.
  • Q3 2025: 13F-HR filed Nov 14, 2025, listing 1 security.
  • Q2 2025: 13F-HR filed Aug 14, 2025, listing 1 security.

What a Form 13F does and does not show